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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Theaflavins, the oxidation products of tea polyphenols are
important biologically active components of black tea. 6 hydroxy 
dopamine is a pro parkinsonian neurotoxin. Theaflavins could
inhibit the auto oxidation of 6 hydroxydopamine in a dose 
dependent manner from 0.5 µg/ml to 25 µg/ml. Here we investi 
gated the protective effect of theaflavins on 6 hydroxydopamine
induced SH SY5Y cells against apoptosis (within this concentra 
tion range). It was found that pretreating SH SY5Y cells with
0.5 µg/ml of theaflavins prevented 6 hydroxydopamine induced
loss of cell viability, condensed nuclear morphology, attenuated
6 hydroxydopamine induced apoptosis, decrease of mitochondrial
membrane potential and the increase of intracellular nitric oxide
levels. Our results indicated that theaflavins had protective effect
against 6 hydroxydopamine induced apoptosis at low concentra 
tions, possibly through inhibition of reactive oxygen species and
nitric oxide production.
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Introduction Parkinson’s disease (PD) is one of the most common chronic
neurodegenerative movement disorders. It is an age-related
progressive disorder with a prevalence of 1–2% in people over
the age of 50.(1) It is second disorders in neurodegenerative
disorders only to Alzheimer’s disease.(2) The predominant motor
abnormalities seen in patients with PD include bradykinesia,
resting tremor, rigidity, and postural instability. The main patho-
logical characteristic of PD is the loss of pigmented dopamine
(DA)-containing neurons of the substantia nigra pars compacta
(SNc) associated with the presence of intracellular protein aggre-
gates known as Lewy bodies.(3) The prevalence of PD is likely to
increase in the future as the number of elderly people increases
quickly, but in present, there are no drugs which are efficient
without adverse effects, the available therapies do not protect
neuron against dopaminergic neurodegeneration. Therefore, it is
very important to develop new drugs that slow or halt the rate of
progression of PD.(4)
Although the etiologies of neurodegenerative disorders remain
to be clarified, the common disease-modifying factors are con-
firmed including oxidative stress, apoptosis, mitochondrial dys-
function, excitotoxicity, impaired ubiquitine-proteasome system
and inflammation.(5) Among the rest, data from human postmortem
tissue indicate that reactive oxygen species (ROS) and decrements
in mitochondrial complex I activity are important in the patho-
genesis of sporadic PD.(6)
Human neuroblastoma (SH-SY5Y) cell is one of the many PD
cell models used in research. SH-SY5Y cell line possesses many
qualities of substantia nigra neurones and is thus suitable for use as
an in vitro model to study the death of dopaminergic neurons.(7)
When treated by neurotoxins such as 6-hyfroxydopamine (6-
OHDA), SH-SY5Y cells mimic many aspects of the dopaminergic
neuronal death observed in PD caused by the mitochondrial
complex I neurotoxins.(8) 6-OHDA is a neurotoxin which selec-
tively kills dopaminergic neurones, and is widely used to induce
neuronal death in both in vitro and in vivo experimental model of
PD.(7) 6-OHDA can interact with and inhibit complex I in isolated
brain mitochondria,(9) and induce a ROS-related collapse in
mitochondrial membrane potential. It is shown that 6-OHDA can
produce oxidative stress in vivo as well as in vitro.(10)
Theaflavins (TFs) are the oxidation products of green tea
polyphenols which are regarded as the important biologically
active components of black tea that can provide health beneﬁts
like anticancer effect.(11) TFs are a mixture that have been found to
have 19 different structure related compounds, and there are four
major black tea TFs: including theaflavin (TF-1), theaflavin-3-
gallate (TF-2A and TF-2B), and theaflavin-3,3-digallate (TF-3)
(Fig. 1).
We’ve known that green tea have neuroprotective effects in
models of degenerative disorders.(2,12,13) Much of the research on
black tea and TFs has been focused on their anticancer pro-
perties,(14) little is known for the neuroprotective effects of black
tea and TFs. In this study, we tested whether TFs might protect
SH-SY5Y cells against 6-OHDA-induced apoptosis through the
ROS–NO pathway. Cell viability was measured by MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetraz-olium bromide] and
sulphorhodamine (SRB) assays. It was found that the cell viability
was significantly higher in SH-SY5Y cells pretreated with 0.5
µg/ml TFs than in control cells. TFs pretreatments also prevented
6-OHDA induced nuclear morphological changes and the decrease
of mitochondrial membrane potential. 6-OHDA induced increase
in intracellular NO level was also inhibited by TFs. The result
showed that TFs had strong protective effect against 6-OHDA
induced apoptosis in SH-SY5Y cells, possibly through inhibition
of ROS and NO production.
Materials and Methods
Chemicals. Dulbecco’s modified Eagle’s medium (DMEM),
newborn bovine serum (FBS), 4-(2-hydroxyethyl)-piperazine-1-
erhane-sulfonic acid (HEPES), 3-(4,5-dimethylthiazol-2-yl)-2,5-




BRL (NY). Dimethyl sulfoxide (DMSO), 6-Hydroxydop-amine
(6-OHDA), DNase I, Hoechst 33258, Propidium iodide (PI),
trypsin, penicillin, and streptomycin were purchased from Sigma
Chemical Co. (MO); Theaflavins were provided by Zhejiang
university. All other chemicals made in China were analytical grade.
Cell Culture. Human neuroblastoma SHSY-5Y cells were
maintained in a DMEM supplemented with 10% FBS, penicillin
(100 IU/ml), and streptomycin (100 µg/ml) at 37°C in 5% CO2/
95% air with 100% relative humidity. Cells were cultured in 6 cm2
dishes and passaged 3–5 days by trypsinization at 80–90%
confluence. All experiments were performed in cells plated at a
density of 2 × 105 cells/ml on 96-well plates or at a density of
5 × 105 cells/ml in 6-well plates. After 24–36 h, the cells were
exposed to 100 µM 6-OHDA alone for 24 h or pretreated with
different concentrations of TFs for 3 h. In order to avoid the inter-
action between TFs and 6-OHDA in the medium, after 3 h of TFs
treatment, cells were washed three times to remove TFs and then
incubated with 6-OHDA for an additional 24 h.
Measurement of cell viability by MTT assay. MTT assay
was performed as described previously in the literature.(15) Cells
were incubated with MTT (500 µg/ml) at 37°C for 3 h. The
supernatant was removed and the colored formazan was dissolved
in DMSO. The absorbance at 590 nm was measured using a Bio-
Rad 3350 microplate reader. Control cells were processed in the
same way, but without TFs and 6-OHDA treatments. The viability
of SH-SY5Y cells was presented as the percentage of control cells.
Measurement of cell viability by SRB assay. Sulphorho-
damine (SRB) assay was performed as described previously in the
literature(16) with some modification. Cells were fixed with 10%
ice-cold TCA for 1 h at 4°C. After fixation, cells were washed for
five times with distilled water and allowed to dry in the air. Cells
were then incubated with 0.4% (m/v) SRB solution at room
temperature for 30 min. The unbound SRB dye was removed by
washing the plates quickly with 1% (v/v) acetic acid for five times.
The washed plates were dried in the air, and the bound SRB was
solubilized by adding 150 µl of 10 mM unbuffered Tris Base
(pH 10.5) to each well and shaking for 10 min on a shaker plat-
form. The absorbance at 540 nm was measured using a Bio-Rad
3350 microplate reader. The viability of SH-SY5Y cells in each
well was presented as the percentage of control cells.
Morphological changes. The changes in the nuclear mor-
phology of apoptotic cells were investigated by labeling the cells
with the nuclear stain Hoechst 33258 and examining them under
ﬂuorescent microscopy. Brieﬂy, the SH-SY5Y cells pre-plated in
35 mm2 dishes were treated with 6-OHDA for 24 h. For pre-
treatments, TFs were added 3 h before 6-OHDA addition. The cells
were fixed with Carnoy’s fixative consisting of methanol and
glacial acetic acid (3:1, v/v), and stained with Hoechst 33258
(3 mg/ml), the stained cells were then examined under ﬂuorescence
microscopy, and the apoptotic cells were distinguished from
control cells by the presence of a fragmented or highly condensed
nucleus.
Flow cytometric analysis using PI. In order to quantitatively
detect cell apoptosis induced by 6-OHDA, SH-SY5Y cells were
added to each 35 mm2 dishes and treated with 6-OHDA for 24 h.
For pre-treatments, TFs were added 3 h before 6-OHDA addition.
Then each dish cells were centrifuged (1000 rpm, 5 min) to
remove the medium, washed two times with PBS and add 70%
ethanol and incubated for 12 h at 4°C, then centrifuged again
(1000 rpm, 5 min) to remove the medium, washed two times with
PBS, add 0.5 ml PBS with RNAase (50 µg/ml) and incubated for
1h  a t  3 7 °C. After incubation, stained with PI (Final concentration
50 µg/ml) for 30 min at 4°C, and then to analysis by flow cytometry
without exposure to light prior, more than ten thousands events
were analyzed per test in list mode. PI emissions were detected
in the FL2-A channels of cytometry system (Becton Dickinson
Immunocytometry System, San Jose, CA), using emission filters
of 575 nm. Calculate the apoptosis percentage of each sample use
ModifitL1 analysis software.
Measurement of mitochondrial membrane potential.
Mitochondrial membrane potential was measured by the
incorporation of a cationic fluorescent dye rhodamine 123 as
described previously in the literature.(17) After 24 h incubation in
normal medium with or without treatment, the cells were changed
to serum-free medium containing 10 µM rhodamine 123 and
incubated for 15 min at 37°C. The cells were then collected and
the flurescence intensity was analyzed within 15 min by a spectro-
photofluorimeter (Hitachi F-4500, 490 nm excitation and 515 nm
emission).
Measurement of intracellular NO. The intracellular NO
was detected using DAF-2DA as described previously in the
literature(18) with some modifications. DAF-2DA, a nitric oxide
fluorescent probe, can react with NO within viable cells to pro-
duce a fluorescent compound. The cells were collected and re-
suspended in BSS (containing 130 µM NaCl, 5.4 mM KCl,
0.8 mM MgCl2, 1.8 mM CaCl2, 15 mM glucose, and 5 mM Hepes,
pH 7.4) and then incubated with 2 µM DAF-2DA (in DMSO)
for 45 min at 37°C. After washing out the excess probe, the
fluorescence intensity was recorded with a Hitachi F-4500 at
485 nm excitation and 515 nm emission.
Determine the composition of TFs sample by HPLC. The
analytical HPLC was performed as follows: the separation was
Fig. 1. The structures of major TFs. TF 1: R1 = R2 = OH; TF 2: R1 = OH, R2 = gallate or R1 = gallate, R2 = OH; TF 3: R1 = R2 = gallate. J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 135
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completed on a Shim-pack ODS column (150 × 4.6 i.d. mm,
Shimadzu, Japan), which was packed with 5 mm C18 silica. The
operating temperature was maintained at 35°C. The LC mobile
phase consisted of (A) 2% glacial acetic acid and (B) ethyl
acetate = 21:3. The gradient was 82% A and 18% B for 28 min,
76% A and 24% B for 4 min, 82% A and 18% B for 3 min. The
flow rate was kept at 0.8 ml/min. The injection volume was 10.0 µl.
Statistical analysis. All experiments were done in triplicate
or more. One-way ANOVA was used to estimate overall signifi-
cance followed by post hoc Tukey’s tests corrected for multiple
comparisons.(19) Data are presented as means ± SD. A probability
level of 1% (p<0.01) was considered to be significant.
Results
TFs prevent 6 OHDA induced decrease of SH SY5Y cell
viability. MTT and SRB assay are two major techniques used to
assess the cell growth. In this study, we investigated the effect of
TFs on 6-OHDA-induced neuronal cell toxicity using both MTT
and SRB assays. SH-SY5Y cells were incubated with different
concentrations (0.1–300 µg/ml) of TFs and 6-OHDA, and the cell
viability was determined. It was found that the survival rate of
cells treated with low concentrations (0.1–25 µg/ml) of TFs alone
for 24 h didn’t have significant difference when compared with
control cells. However, TFs showed a significant toxicity to SH-
SY5Y cells at higher concentrations (50–300 µg/ml) (Fig. 2A).
The result also showed that 6-OHDA induced cell death in a dose-
dependent manner (data not shown), and the survival rate of
SH-SY5Y was about 60% when the cells were treated with
100 µM 6-OHDA for 24 h. The effects of the pre-treatment of TFs
on the cytotoxicity induced by 6-OHDA were shown to have a
dose-dependent manner as shown in Fig. 2 B and C. At 0.1 µg/ml
concentration, TFs has no significant effects on 6-OHDA-induced
cytotoxicity. At concentrations from 0.5 µg/ml to 25 µg/ml, TFs
pre-treatments showed protective effects against cytotoxicity.
When cells were pretreated with 0.5–2 µg/ml TFs, the cell
viability was significantly higher than that of the control cells
(Fig. 2 B and C). However, at high concentrations (50–300 µg/ml),
TF pretreatments caused more toxicity than 6-OHDA treatment
alone, which is not surprising since TFs themselves induced cell
damage at those concentrations (data not shown).
TFs attenuate 6 OHDA induced changes in nuclear mor 
phology. Normal SH-SY5Y cell nuclei are suborbicular, much
bigger and darker than treatment groups cells (Fig. 2A). Nuclei
apoptosis indicated by condensed nuclei and nuclear fragmenta-
tion were apparent after exposure to 100 µM 6-OHDA for 24 h
(Fig. 3B). These changes in nuclear characteristics of apoptosis
were attenuated significantly in the cells pretreated with 0.5 µg/ml
and 1 µg/ml TFs (Fig. 3 C and D).
TFs attenuate 6 OHDA induced apoptosis through flow
cytometric analysis. Using PI single-stain system to measure
SH-SY5Y cell apoptosis. Typical examples are shown Fig. 4 A–D.
After 24 h of incubation with 6-OHDA, results demonstrated that
the percentage of apoptosis increased significantly (p<0.01)
(Fig. 4B) compared to control cells (Fig. 4A), and TFs showed
a positive effect at 0.5 µg/ml and 1 µg/ml concentration (Fig. 4
C–D). The cell apoptosis rate showed at Fig. 4E.
TFs attenuate 6 OHDA induced decrease in mitochondrial
membrane potential. Mitochondria are important organelles
in the cell. It has been shown that mitochondrial dysfunction
plays an important role in the induction of apoptosis and the
mitochondrial membrane potential is an affected by apoptotic
factors, the earliest recorded change is the reduction of mitochon-
drial membrane potential, and then cells enter the irreversible
apoptotic process.(20)
After SH-SY5Y cells were exposed to 6-OHDA for 24 h, the
fluorescent intensity of rhodamine 123 staining of the cells was
decreased, representing a fall in the mitochondrial membrane
Fig. 2. Effects of 6 OHDA and TFs on SH SY5Y cell viability. (A) Cells
were incubated in medium containing different concentrations of TFs
for 24 h. The cell viability was determined by MTT assay. (B) Cells were
pre incubated with different concentrations of TFs for 3 h, then treated
with 100 μM 6 OHDA for an additional 24 h and the cell viability was
measured by MTT assay. (C) Cells were pre incubated with different
concentrations of TFs for 3 h, then treated with 100 μM 6 OHDA for an
additional 24 h and the cell viability was measured by SRB assay. Data
are expressed as percentage of the untreated control means ± SD, n =7 .
*p<0.01 significantly different from untreated control cells and
**p<0.01 significantly different from 6 OHDA group.doi: 10.3164/jcbn.11 28
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potential. Since low concentrations of TFs (0.5–25 µg/ml) protected
cells against 6-OHDA toxicity, we tested whether pre-treatments
of TFs (0.5 µg/ml, 1 µg/ml, 2 µg/ml) before 100 µM 6-OHDA
treatment affected mitochondrial membrane potential. The results
showed that TFs at this concentrations have significantly inhibited
the fall of mitochondrial membrane potential caused by 6-OHDA
at 100 µM (Fig. 5).
TFs attenuate 6 OHDA induced increase of intracellular
NO in SH SY5Y cells. High concentration of NO shows cyto-
toxic effects, causing nerve damage. Excessive NO is produced
from the reaction of peroxynitrite (ONOO−) with O2, and causes
damage to cell NDA, enhancing the expression of P53, and
leading to cell apoptosis.(21)
SH-SY5Y cells treated with 6-OHDA increased intracellular
NO level by 45%. TFs pretreatments inhibited the increase of
intracellular NO levels. The increase in NO levels was reduced in
a concentration-dependent manner by pretreatment of TFs in 0.5–
2 µg/ml range (Fig. 6).
The composition of TFs sample. The result (Fig. 7) showed
that the purity of our TFs is 81.89%, containing TF, TF-3-G, TF-3'-
G and TFDG (the peak of retention time at 8 min in Fig. 7 is
EGCG, one monomer of green tea polyphenols). Like EGCG that
is considered as the main active component of green tea poly-
phenols, there may be a monomer in TFs which is the main active
component against neuronal cell death. We are in process to
separate the monomers from TFs, and may find out which
monomer is the most efficient for PD prevention in the future.
Discussion
The direct cause of neuro-degeneration in PD is the selective
loss of dopaminergic neurons in the substantia nigra, and apoptosis
has also been suggested to be involved in this process.(22) 6-OHDA
is a mitochondrial complex I inhibitor which can reproduce PD-
like cell damage both in vivo and in vitro.(23) 6-OHDA can induce
apoptosis in many kinds of cells that secrete dopamine and possess
dopamine transporters. SH-SY5H and PC12 are both frequently
used as cell models for PD. Previous literature showed that pre-
treatment of black tea extracts (BT) at the concentrations of
Fig. 3. Effect of TFs on 6 OHDA induced apoptotic nuclear morphology
in SH SY5Y cells. Fluorescence micrographs of SH SY5Y cell nuclei from
untreated cells (A); cells exposed to 100 μM 6 OHDA for 24 h (B); Cells
pre incubated with 0.5 μg/ml TFs (C) or 1 μg/ml TFs (D) for 3 h, and
treated with 100 μM 6 OHDA for 24 h. The cells were stained with the
DNA binding fluorochrome Hoechst 33258. Scale bar = 50 μm.
Fig. 4. Cell apoptosis detected by flow cytometry. SH SY5Y cells were
incubated in drug free medium (A) or medium containing with 100 μM
6 OHDA for 24 h (B); or cells were pre incubated with 0.5 μg/ml TFs (C)
or 1 μg/ml TFs (D) for 3 h. The results shown in (E) are the cell apoptosis
rate of the means and SE for two independent experiments. The cells
were stained with PI. Data are expressed as percentage of the dead
cells means ± SD, n = 2. *p<0.01 significantly different from untreated
control cells and **p<0.01 significantly different from 6 OHDA group. J. Clin. Biochem. Nutr. | March 2012 | vol. 50 | no. 2 | 137
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0.6–6 µM had protective effects against neurotoxin-induced NB
SH-SY5Y and PC12 cell death by MTT test,(24) whereas the full
composition of the BT was not known (20% similar polyphenols
concentrations as green tea extracts). Meanwhile, researches
about neuroprotective effects of TFs are not as much as catechins.
According to this, our research focused on the research of neuro-
protective effects of TFs, and the results showed that low concen-
trations of TFs prevented 6-OHDA-induced loss of SH-SY5Y cell
viability, rescued 6-OHDA-induced nuclear morphological changes
and the decrease of mitochondrial membrane potential, and
attenuated 6-OHDA-induced apoptosis through flow cytometric
analysis. In addition, the increase of intracellular NO levels
induced by 6-OHDA was also inhibited by TFs. These results
indicated that TFs had strong protective effect against 6-OHDA-
induced apoptosis in SH-SY5Y cells, possibly through inhibition
of NO production. This suggests that TFs may have the effect for
PD prevention.
In this study, we used two ways to testify the cell viability
changes, MTT and SRB essay. MTT assay is much simpler than
SRB and easy to manipulate so may cause less subjective errors.
Fig. 7. The constituents of TFs detected by HPLC.
Fig. 5. TFs attenuate 6 OHDA induced decrease of mitochondrial
membrane potential. Cells exposed to 6 OHDA were incubated with
rhodamine 123, and the fluorescence intensity was measured. MMP of
control is defined as 100% and the data are expressed as percentage of
the untreated control means ± SD, n = 5. *p<0.01 significantly different
from untreated control cells and **p<0.01 significantly different from
6 OHDA group.
Fig. 6. TFs attenuated 6 OHDA induced increase of intracellular NO in
SH SY5Y cells. Cells were incubated with DAF 2DA, and the fluorescence
intensity was recorded. Data are expressed as percentage of the
untreated control means ± SD, n =3 ,  * p<0.01 significantly different from




But the SRB assay is sensitive, reproducible and more rapid than
the formazan-based assays and gives better linearity, a good
signal-to-noise ratio and has a stable end-point that does not
require a time-sensitive measurement, as do the MTT assay.
In previous researches, TFs have been mostly used for their
anticancer properties, little is known for their cell protection
effect. We noticed that the concentrations of TFs used in the
anticancer researches were much higher than the concentration
used in our study. So TFs may have different effects when used at
different concentrations. They may protect neuronal cells at low
concentrations and cause apoptosis of cancer cells at high concen-
trations.
In our study, the HPLC result (Fig. 7) showed that our TFs
mainly containing TF, TF-3-G, TF-3'-G and TFDG. Like EGCG
that is considered as the main active component of green tea
polyphenols, there may be a monomer in TFs which is the main
active component against neuronal cell death. We are in process to
separate the monomers from TFs, and may find out which
monomer is the most efficient for PD prevention in the future.
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